A NKp80-Based Identification Strategy Reveals that CD56<sup>neg</sup> NK Cells Are Not Completely Dysfunctional in Health and Disease.

Orrantia, Ane; Terrén, Iñigo; Izquierdo-Lafuente, Alicia; Alonso-Cabrera, Juncal A; Sandá, Victor; Vitallé, Joana; Moreno, Santiago; Tasias, María; Uranga, Alasne; González, Carmen; Mateos, Juan J; García-Ruiz, Juan C; Zenarruzabeitia, Olatz; Borrego, Francisco

A NKp80-Based Identification Strategy Reveals that CD56^neg NK Cells Are Not Completely Dysfunctional in Health and Disease.

Orrantia, Ane; Terrén, Iñigo; Izquierdo-Lafuente, Alicia; Alonso-Cabrera, Juncal A; Sandá, Victor; Vitallé, Joana; Moreno, Santiago; Tasias, María; Uranga, Alasne; González, Carmen; Mateos, Juan J; García-Ruiz, Juan C; Zenarruzabeitia, Olatz; Borrego, Francisco.

Afiliação

Orrantia A; Biocruces Bizkaia Health Research Institute, Immunopathology Group, Barakaldo 48903, Spain.
Terrén I; Biocruces Bizkaia Health Research Institute, Immunopathology Group, Barakaldo 48903, Spain.
Izquierdo-Lafuente A; Biocruces Bizkaia Health Research Institute, Immunopathology Group, Barakaldo 48903, Spain.
Alonso-Cabrera JA; Biocruces Bizkaia Health Research Institute, Immunopathology Group, Barakaldo 48903, Spain.
Sandá V; Biocruces Bizkaia Health Research Institute, Immunopathology Group, Barakaldo 48903, Spain.
Vitallé J; Biocruces Bizkaia Health Research Institute, Immunopathology Group, Barakaldo 48903, Spain.
Moreno S; Ramón y Cajal Health Research Institute (IRYCIS), Ramón y Cajal University Hospital, Madrid 28034, Spain.
Tasias M; Hospital Universitari i Politecnic La Fe, Valencia 46026, Spain.
Uranga A; Biodonostia Health Research Institute, Donostia University Hospital, Donostia-San Sebastián 20014, Spain.
González C; Biodonostia Health Research Institute, Donostia University Hospital, Donostia-San Sebastián 20014, Spain.
Mateos JJ; Biocruces Bizkaia Health Research Institute, Hematological Cancer Group, Cruces University Hospital, Barakaldo 48903, Spain.
García-Ruiz JC; Biocruces Bizkaia Health Research Institute, Hematological Cancer Group, Cruces University Hospital, Barakaldo 48903, Spain.
Zenarruzabeitia O; Biocruces Bizkaia Health Research Institute, Immunopathology Group, Barakaldo 48903, Spain.
Borrego F; Biocruces Bizkaia Health Research Institute, Immunopathology Group, Barakaldo 48903, Spain; Ikerbasque, Basque Foundation for Science, Bilbao 48013, Spain. Electronic address: francisco.borregorabasco@osakidetza.eus.